Kalbe Farma (Indonesia) Today
| KLBF Stock | IDR 1,030 15.00 1.48% |
PerformanceVery Weak
| Odds Of DistressLow
|
Kalbe Farma is selling for 1030.00 as of the 20th of March 2025. This is a 1.48 percent up since the beginning of the trading day. The stock's last reported lowest price was 1010.0. Kalbe Farma has less than a 9 % chance of experiencing financial distress in the next few years, but has generated negative returns over the last 90 days. The performance scores are derived for the period starting the 20th of December 2024 and ending today, the 20th of March 2025. Click here to learn more.
Moving together with Kalbe Stock
| 0.68 | BBRI | Bank Rakyat Indonesia | PairCorr |
| 0.69 | BMRI | Bank Mandiri Persero | PairCorr |
| 0.75 | GGRM | Gudang Garam Tbk Earnings Call This Week | PairCorr |
| 0.84 | HMSP | Hanjaya Mandala Sampoerna Earnings Call This Week | PairCorr |
Moving against Kalbe Stock
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
Kalbe Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Kalbe Farma's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Kalbe Farma or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| Business Concentration | Health Care, Pharmaceuticals, Pharmaceuticals And Biosciences, Healthcare (View all Sectors) |
Kalbe Farma Tbk (KLBF) is traded on Jakarta Exchange in Indonesia and employs 12,644 people. The company currently falls under 'Mega-Cap' category with a current market capitalization of 104.08 T. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Kalbe Farma's market, we take the total number of its shares issued and multiply it by Kalbe Farma's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Kalbe Farma Tbk operates under Pharmaceuticals sector and is part of Health Care industry. The entity has 46.26 B outstanding shares.
Kalbe Farma Tbk has accumulated about 3.32 T in cash with 2.83 T of positive cash flow from operations.
Check Kalbe Farma Probability Of Bankruptcy
Ownership AllocationKalbe Farma Tbk maintains a total of 46.26 Billion outstanding shares. Kalbe Farma Tbk holds significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Since such a large part of the company is owned by insiders, it is advisable to analyze if each of these insiders have been buying or selling the stock in recent months. Please note that no matter how many assets the company has, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Check Kalbe Ownership Details
Kalbe Farma Tbk Risk Profiles
Although Kalbe Farma's alpha and beta are two of the key measurements used to evaluate Kalbe Farma's performance over the market, the standard measures of volatility play an important role as well.
| Mean Deviation | 2.3 | |||
| Standard Deviation | 2.95 | |||
| Variance | 8.71 | |||
| Risk Adjusted Performance | (0.09) |
Kalbe Stock Against Markets
Be your own money manager
Our tools can tell you how much better you can do entering a position in Kalbe Farma without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Volatility Analysis Now
Volatility AnalysisGet historical volatility and risk analysis based on latest market data |
| All Next | Launch Module |
Kalbe Farma Corporate Management
Elected by the shareholders, the Kalbe Farma's board of directors comprises two types of representatives: Kalbe Farma inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Kalbe. The board's role is to monitor Kalbe Farma's management team and ensure that shareholders' interests are well served. Kalbe Farma's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Kalbe Farma's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Lanny Soputro | G HR | Profile | |
| Kurniawan Suhartono | Head Unit | Profile | |
| Sie Djohan | Management Devel | Profile | |
| Lukito Gozali | Head Relations | Profile |
Other Information on Investing in Kalbe Stock
Kalbe Farma financial ratios help investors to determine whether Kalbe Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Kalbe with respect to the benefits of owning Kalbe Farma security.